Biosign Technologies (BITKF) 0.0185 $BITKF Bios
Post# of 273242
Posted On: 05/18/2015 2:22:45 AM
Biosign Technologies (BITKF) 0.0185 $BITKF
Biosign Announces Results of Shareholders Meeting
CNW Group - Wed May 06, 7:46PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that it held an annual and special meeting of shareholders on May 5, 2015 where all of the items of business of the Company were approved, including:
BIO.VN: 0.010 (unch)
Biosign withdraws from acquisition of QLINE Solutions Inc.
CNW Group - Mon Jan 26, 6:16PM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced its Board of Directors has decided to withdraw from the acquisition of QLINE Solutions Inc. ("QLINE". The Company had executed a Share Purchase Agreement under which Biosign acquired 100% of the issued and outstanding shares of QLINE for a total price of $3.03 million including $830,000 to be paid in cash and the issuance of 44,000,000 common shares of Biosign at an ascribed value of $0.05 per share. Only $30,000 of the cash portion has been paid which will be retained by the sellers and all 44,000,000 shares held in trust will be returned to Biosign for cancellation.
BIO.VN: 0.010 (unch)
Biosign Secures License Sale with the Release of an Enterprise Version of its Clinic Management Software
CNW Group - Tue Jan 20, 6:57AM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" is pleased to announce that it has signed an initial one year user-based network license agreement with a substantial multi-national corporation, consisting of a large network of physiotherapy, paramedical and rehab clinics and an associated technology services group. Under this contract Biosign will host the new Enterprise Version of its cloud-based ClinicServer practice management solution. The release of the Enterprise Version will significantly expand the market for the ClinicServer practice management solution. This innovative cloud solution will empower our new customer to manage its complex multi-jurisdictional clinical operations from a centralized and unified technology base. Use of this Enterprise Version will substantially increase their operational efficiencies and also facilitate a new level of electronic payment processing into their expanding network of clinics. The customer has over 1500 clinics in its group of companies and our solution is currently being rolled-out to the North American division over the next two months.
BIO.VN: 0.010 (unch)
Biosign restructures demand loans
CNW Group - Mon Jan 05, 7:31AM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announces that the demand loans payable to Quindell Solutions Inc. ("Quindell" totalling $6.8 million plus all accrued interest of circa $180,000 ("Accrued Interest" have been converted to a loan repayable over a period of 5 years ("Term Loan". The Term Loan accrues interest at the rate of 2% per annum above prime rate.
BIO.VN: 0.010 (unch)
Biosign closes acquisition of QLINE Solutions Inc.
CNW Group - Tue Nov 04, 4:00PM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announces that it has formally closed the acquisition of 100% of the issued and outstanding shares of Peterborough, Ontario based QLINE Solutions Inc. ("QLINE". The Company announced on January 6, 2014, that the parties had executed a Share Purchase Agreement under which Biosign agreed to acquire 100% of QLINE for a total price of $3 million.
BIO.VN: 0.010 (unch)
Biosign completes sale of hardware division and unwinds investment in Higher Bracket Online Media Inc.
CNW Group - Wed Sep 17, 4:25PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announces that it has completed the sale of its hardware division to Cloud DX Inc. ("Cloud DX". On August 11, 2014, Biosign announced it had reached an agreement in principle to sell certain assets related to the Company's Pulsewave medical device product line ("the Agreement" with Vancouver-based Global Life Safety Group Inc. ("Global". Cloud DX, a New York-based affiliate of Global, acquired the Pulsewave assets, intellectual property and certain other intangible assets, for a total purchase price of $2,000,000 to be paid over 5 years with minimum payments of $100,000 per year. Biosign was paid $25,000 on closing and an additional $80,000 is expected to be received from Cloud DX on or before October 15, 2014. Payments will be accelerated upon satisfaction of certain financing and other milestones achieved by Cloud DX. In addition, Cloud DX has assumed the operating costs of the Pulsewave division, including various real estate, physical plant, human capital, R&D and manufacturing expenses. As part of this transaction, Biosign has been granted distribution rights from Cloud DX as well as the ability to integrate Pulsewave and future related products with Biosign solutions.
BIO.VN: 0.010 (unch)
Biosign sells 12.5% of MECK Medical GmbH to raise additional funds
CNW Group - Thu Aug 28, 5:56PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced the completion of a Share Purchase Agreement (the "SPA" with 3282909 Nova Scotia Limited ("the Investor" under which it has sold 12.5% of its 51% ownership stake of the issued and outstanding shares of MECK Medical GmbH ("MECK" previously acquired on June 30, 2014. The Investor who paid $400,000 on closing for the stake in MECK is a corporation owned by Dr. Michael Gross who is Chairman and acting CEO of Biosign. The Investor has committed to pay an additional $75,000 subsequent to closing.
BIO.VN: 0.010 (unch)
Biosign Agrees to Sell its Hardware Division; Resignation of CEO and Director; Appointment of New CEO
CNW Group - Mon Aug 11, 8:00AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced it has reached an agreement in principle with Vancouver-based Global Life Safety Group Inc. ("Global) to divest certain assets related to the Company's Pulsewave® medical device product line. Following completion of such transaction, the Company intends to focus on delivering healthcare IT solutions through the faster-growing software divisions of the Company, including particularly AioMed GmbH in Germany.
BIO.VN: 0.010 (unch)
Biosign Adds Ron Kelusky to the Board of Directors
CNW Group - Thu Jul 24, 3:01PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" is pleased to announce the appointment of Ron Kelusky to the Board. Mr. Kelusky is the President & CEO of Public Services Health & Safety Association of Ontario (PSHSA). PSHSA works with Ontario's 10,000 public and broader public service sector employers and 1.5 million workers, offering consulting, training, resources, plus health & safety products and information to clients in health and community care, education and culture, municipal and provincial government, and public safety and First Nations communities. From 2009-2013 Mr Kelusky was Director General of the Canadian Red Cross, responsible for Ontario operations and all National Health programming, overseeing 4,000 full and part time staff, 6,000 volunteers and an annual operating budget of $175.0 million. From 2006 - 2009 he was President, Health Division for GestureTek Incorporated; from 2003-2006 he was Chief Operating Officer for March of Dimes Canada; and from 1998-2003 he served as Chief and General Manager for the City of Toronto Emergency Medical Services. Mr. Kelusky has an MBA from Athabasca University.
BIO.VN: 0.010 (unch)
Biosign Closes Acquisition of 51% of Meck Medical GmbH, secures demand loan and seeks further financing
CNW Group - Fri Jul 04, 5:23PM CDT
Biosign Technologies Inc. (TSXV: BIO) (the "Company" is pleased to announce that it has completed the previously-announced acquisition of 51% of issued and outstanding shares of Meck Medical GmbH ("MECK". Klingenberg Germany-based MECK is a developer of innovative healthcare software solutions assembled into a cloud-based platform that provides facility management services, document management, prescription management, wound management and social networking services to the long term care, nursing home and extended care industries in Germany.
BIO.VN: 0.010 (unch)
Biosign Technologies Inc. - Resignation of Board Director
CNW Group - Wed Jul 02, 5:03PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced that Mr. John-Peter Bradford has resigned from the Board, effective June 27th, 2014.
BIO.VN: 0.010 (unch)
Biosign Acquires 51% of Meck Medical GmbH
CNW Group - Thu Jun 19, 4:05PM CDT
/Not for distribution in the United States or through United States wire services/
BIO.VN: 0.010 (unch)
Biosign Announces Results of Shareholders Meeting
CNW Group - Wed May 06, 7:46PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that it held an annual and special meeting of shareholders on May 5, 2015 where all of the items of business of the Company were approved, including: BIO.VN: 0.010 (unch)
Biosign withdraws from acquisition of QLINE Solutions Inc.
CNW Group - Mon Jan 26, 6:16PM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced its Board of Directors has decided to withdraw from the acquisition of QLINE Solutions Inc. ("QLINE". The Company had executed a Share Purchase Agreement under which Biosign acquired 100% of the issued and outstanding shares of QLINE for a total price of $3.03 million including $830,000 to be paid in cash and the issuance of 44,000,000 common shares of Biosign at an ascribed value of $0.05 per share. Only $30,000 of the cash portion has been paid which will be retained by the sellers and all 44,000,000 shares held in trust will be returned to Biosign for cancellation. BIO.VN: 0.010 (unch)
Biosign Secures License Sale with the Release of an Enterprise Version of its Clinic Management Software
CNW Group - Tue Jan 20, 6:57AM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
is pleased to announce that it has signed an initial one year user-based network license agreement with a substantial multi-national corporation, consisting of a large network of physiotherapy, paramedical and rehab clinics and an associated technology services group. Under this contract Biosign will host the new Enterprise Version of its cloud-based ClinicServer practice management solution. The release of the Enterprise Version will significantly expand the market for the ClinicServer practice management solution. This innovative cloud solution will empower our new customer to manage its complex multi-jurisdictional clinical operations from a centralized and unified technology base. Use of this Enterprise Version will substantially increase their operational efficiencies and also facilitate a new level of electronic payment processing into their expanding network of clinics. The customer has over 1500 clinics in its group of companies and our solution is currently being rolled-out to the North American division over the next two months. BIO.VN: 0.010 (unch)
Biosign restructures demand loans
CNW Group - Mon Jan 05, 7:31AM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that the demand loans payable to Quindell Solutions Inc. ("Quindell" totalling $6.8 million plus all accrued interest of circa $180,000 ("Accrued Interest" have been converted to a loan repayable over a period of 5 years ("Term Loan". The Term Loan accrues interest at the rate of 2% per annum above prime rate. BIO.VN: 0.010 (unch)
Biosign closes acquisition of QLINE Solutions Inc.
CNW Group - Tue Nov 04, 4:00PM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that it has formally closed the acquisition of 100% of the issued and outstanding shares of Peterborough, Ontario based QLINE Solutions Inc. ("QLINE". The Company announced on January 6, 2014, that the parties had executed a Share Purchase Agreement under which Biosign agreed to acquire 100% of QLINE for a total price of $3 million. BIO.VN: 0.010 (unch)
Biosign completes sale of hardware division and unwinds investment in Higher Bracket Online Media Inc.
CNW Group - Wed Sep 17, 4:25PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that it has completed the sale of its hardware division to Cloud DX Inc. ("Cloud DX". On August 11, 2014, Biosign announced it had reached an agreement in principle to sell certain assets related to the Company's Pulsewave medical device product line ("the Agreement" with Vancouver-based Global Life Safety Group Inc. ("Global". Cloud DX, a New York-based affiliate of Global, acquired the Pulsewave assets, intellectual property and certain other intangible assets, for a total purchase price of $2,000,000 to be paid over 5 years with minimum payments of $100,000 per year. Biosign was paid $25,000 on closing and an additional $80,000 is expected to be received from Cloud DX on or before October 15, 2014. Payments will be accelerated upon satisfaction of certain financing and other milestones achieved by Cloud DX. In addition, Cloud DX has assumed the operating costs of the Pulsewave division, including various real estate, physical plant, human capital, R&D and manufacturing expenses. As part of this transaction, Biosign has been granted distribution rights from Cloud DX as well as the ability to integrate Pulsewave and future related products with Biosign solutions. BIO.VN: 0.010 (unch)
Biosign sells 12.5% of MECK Medical GmbH to raise additional funds
CNW Group - Thu Aug 28, 5:56PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced the completion of a Share Purchase Agreement (the "SPA" with 3282909 Nova Scotia Limited ("the Investor" under which it has sold 12.5% of its 51% ownership stake of the issued and outstanding shares of MECK Medical GmbH ("MECK" previously acquired on June 30, 2014. The Investor who paid $400,000 on closing for the stake in MECK is a corporation owned by Dr. Michael Gross who is Chairman and acting CEO of Biosign. The Investor has committed to pay an additional $75,000 subsequent to closing. BIO.VN: 0.010 (unch)
Biosign Agrees to Sell its Hardware Division; Resignation of CEO and Director; Appointment of New CEO
CNW Group - Mon Aug 11, 8:00AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced it has reached an agreement in principle with Vancouver-based Global Life Safety Group Inc. ("Global) to divest certain assets related to the Company's Pulsewave® medical device product line. Following completion of such transaction, the Company intends to focus on delivering healthcare IT solutions through the faster-growing software divisions of the Company, including particularly AioMed GmbH in Germany. BIO.VN: 0.010 (unch)
Biosign Adds Ron Kelusky to the Board of Directors
CNW Group - Thu Jul 24, 3:01PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
is pleased to announce the appointment of Ron Kelusky to the Board. Mr. Kelusky is the President & CEO of Public Services Health & Safety Association of Ontario (PSHSA). PSHSA works with Ontario's 10,000 public and broader public service sector employers and 1.5 million workers, offering consulting, training, resources, plus health & safety products and information to clients in health and community care, education and culture, municipal and provincial government, and public safety and First Nations communities. From 2009-2013 Mr Kelusky was Director General of the Canadian Red Cross, responsible for Ontario operations and all National Health programming, overseeing 4,000 full and part time staff, 6,000 volunteers and an annual operating budget of $175.0 million. From 2006 - 2009 he was President, Health Division for GestureTek Incorporated; from 2003-2006 he was Chief Operating Officer for March of Dimes Canada; and from 1998-2003 he served as Chief and General Manager for the City of Toronto Emergency Medical Services. Mr. Kelusky has an MBA from Athabasca University. BIO.VN: 0.010 (unch)
Biosign Closes Acquisition of 51% of Meck Medical GmbH, secures demand loan and seeks further financing
CNW Group - Fri Jul 04, 5:23PM CDT
Biosign Technologies Inc. (TSXV: BIO) (the "Company"
is pleased to announce that it has completed the previously-announced acquisition of 51% of issued and outstanding shares of Meck Medical GmbH ("MECK". Klingenberg Germany-based MECK is a developer of innovative healthcare software solutions assembled into a cloud-based platform that provides facility management services, document management, prescription management, wound management and social networking services to the long term care, nursing home and extended care industries in Germany. BIO.VN: 0.010 (unch)
Biosign Technologies Inc. - Resignation of Board Director
CNW Group - Wed Jul 02, 5:03PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced that Mr. John-Peter Bradford has resigned from the Board, effective June 27th, 2014. BIO.VN: 0.010 (unch)
Biosign Acquires 51% of Meck Medical GmbH
CNW Group - Thu Jun 19, 4:05PM CDT
/Not for distribution in the United States or through United States wire services/
BIO.VN: 0.010 (unch)
(0)
(0)Scroll down for more posts ▼